{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:22:40Z","timestamp":1793125360632,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1124\/jpet.300.3.729","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:32:29Z","timestamp":1042223549000},"page":"729-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Role of Inflammatory Mediators in Thrombogenesis"],"prefix":"10.1016","volume":"300","author":[{"given":"Ronald J.","family":"Shebuski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Kilgore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.300.3.729_bib1","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1073\/pnas.250475997","article-title":"Pro-coagulant state resulting from high levels of soluble P-selectin in blood.","volume":"97","author":"Andre","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.300.3.729_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(98)00635-4","article-title":"Platelet activation in patients after an acute coronary syndrome: Results from the TIMI-12 trial.","volume":"33","author":"Ault","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.300.3.729_bib3","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1182\/blood.V89.9.3270","article-title":"Mechanism of tissue factor activation on HL-60 cells.","volume":"89","author":"Bach","year":"1997","journal-title":"Blood"},{"key":"10.1124\/jpet.300.3.729_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00019501-199404000-00010","article-title":"The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes.","volume":"5","author":"Becker","year":"1994","journal-title":"Coron Artery Dis"},{"key":"10.1124\/jpet.300.3.729_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archsurg.1995.01430070061012","article-title":"Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis.","volume":"130","author":"Boermeester","year":"1995","journal-title":"Arch Surg"},{"key":"10.1124\/jpet.300.3.729_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/01.CIR.103.8.1128","article-title":"Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine.","volume":"103","author":"Bienvenu","year":"2001","journal-title":"Circulation"},{"key":"10.1124\/jpet.300.3.729_bib7","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.91.19.8767","article-title":"P-selectin induces the expression of tissue factor on monocytes.","volume":"91","author":"Celi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.300.3.729_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1009811819077","article-title":"New potential therapeutic modalities: tissue factor pathway inhibitor.","volume":"3","author":"Creasey","year":"1999","journal-title":"Sepsis"},{"key":"10.1124\/jpet.300.3.729_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/35006574","article-title":"Peptide exosite inhibitors of factor VIIa as anticoagulants.","volume":"404","author":"Dennis","year":"2000","journal-title":"Nature (Lond)"},{"issue":"Suppl 2","key":"10.1124\/jpet.300.3.729_bib10","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00005344-199500252-00004","article-title":"Cytokines and thrombosis.","volume":"25","author":"Dosquet","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.300.3.729_bib11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0741-5214(97)70211-8","article-title":"Anti-P-selectin antibody decreases inflammation and venous thrombus formation.","volume":"25","author":"Downing","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.1124\/jpet.300.3.729_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.175.4.1147","article-title":"Characterization of GMP-140 (P-selectin) as a circulating plasma protein.","volume":"174","author":"Dunlop","year":"1992","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.300.3.729_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0049-3848(96)00139-9","article-title":"Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor.","volume":"83","author":"Ernofsson","year":"1996","journal-title":"Thromb Res"},{"key":"10.1124\/jpet.300.3.729_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0037-1616200","article-title":"Role of coagulation inhibitors in inflammation.","volume":"86","author":"Esmon","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.191.8.1413","article-title":"P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo.","volume":"191","author":"Frenette","year":"2000","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.300.3.729_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0038-1657544","article-title":"Leukocyte crosstalk at the vascular wall.","volume":"78","author":"Furie","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib17","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"Blood-borne tissue factor: another view of thrombosis.","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.300.3.729_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2000-8456","article-title":"Tissue factor on the loose.","volume":"26","author":"Giesen","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/jpet.300.3.729_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1126\/science.1972598","article-title":"Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.","volume":"248","author":"Girard","year":"1990","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.300.3.729_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0038-1642664","article-title":"Endothelial cell function, including tissue factor expression, under flow conditions.","volume":"74","author":"Grabowski","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib21","first-page":"967","article-title":"Cytokines and hemostasis.","volume":"85","author":"Grignani","year":"2000","journal-title":"Haematologica"},{"key":"10.1124\/jpet.300.3.729_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-8703(00)90242-4","article-title":"Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department.","volume":"139","author":"Gurbel","year":"2000","journal-title":"Am Heart J"},{"key":"10.1124\/jpet.300.3.729_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00019501-199809070-00008","article-title":"Increased baseline levels of platelet P-selectin and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis.","volume":"9","author":"Gurbel","year":"1998","journal-title":"Coron Artery Dis"},{"key":"10.1124\/jpet.300.3.729_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0145-2126(95)00107-7","article-title":"Tissue factor expression in human leukemic cells.","volume":"20","author":"Hair","year":"1996","journal-title":"Leuk Res"},{"issue":"Suppl 1","key":"10.1124\/jpet.300.3.729_bib25","first-page":"76","article-title":"(1997) Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.","volume":"26","author":"Harker","year":"1997","journal-title":"Haemostasis"},{"key":"10.1124\/jpet.300.3.729_bib26","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.CIR.102.14.1710","article-title":"Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries.","volume":"102","author":"Hayashi","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/jpet.300.3.729_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0037-1615608","article-title":"Inhibition of arterial thrombosis by a soluble tissue factor mutant and active-site blocked factors IXa and Xa in the guinea pig.","volume":"85","author":"Himber","year":"2001","journal-title":"Thromb Hameost"},{"key":"10.1124\/jpet.300.3.729_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0735-1097(99)00175-8","article-title":"Risk stratification of emergency department patients with acute coronary syndromes using P-selectin.","volume":"34","author":"Hollander","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.300.3.729_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood.V86.3.1027.1027","volume":"86","author":"Jansen","year":"1995","journal-title":"Blood"},{"key":"10.1124\/jpet.300.3.729_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.RES.88.2.159","article-title":"Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development.","volume":"88","author":"Kawasaki","year":"2001","journal-title":"Circ Res"},{"key":"10.1124\/jpet.300.3.729_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3565(24)39276-6","article-title":"Pharmacokinetics, pharmacodynamcis, allometry, and dose selection for PSGL-1 for phase I trial.","volume":"293","author":"Khor","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.3.729_bib32","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1161\/01.CIR.96.12.4333","article-title":"Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice.","volume":"96","author":"Kumar","year":"1997","journal-title":"Circulation"},{"key":"10.1124\/jpet.300.3.729_bib33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.99.10.1363","article-title":"Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.","volume":"99","author":"Kumar","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/jpet.300.3.729_bib34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.1439808","article-title":"Selectins: interpreters of cell-specific carbohydrate information during inflammation.","volume":"258","author":"Lasky","year":"1992","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.300.3.729_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0162-3109(00)00206-X","article-title":"Inhibition of p38 MAP kinase as a therapeutic strategy.","volume":"47","author":"Lee","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1124\/jpet.300.3.729_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2362.1997.570614.x","article-title":"The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia.","volume":"27","author":"Levi","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.300.3.729_bib37","doi-asserted-by":"crossref","first-page":"3J","DOI":"10.1016\/S0002-9149(00)01339-4","article-title":"Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization.","volume":"86","author":"Libby","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.300.3.729_bib38","first-page":"312","volume":"36","author":"Lincoff","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.300.3.729_bib39","first-page":"S49","article-title":"Cell-cell interaction and tissue factor expression.","volume":"1","author":"Lorenzet","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1124\/jpet.300.3.729_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0038-1657623","article-title":"Regulation of the tissue factor gene.","volume":"78","author":"Mackman","year":"1997","journal-title":"Thromb Haemost"},{"issue":"Suppl 11","key":"10.1124\/jpet.300.3.729_bib41","first-page":"S97","article-title":"Role of PSGL-1 binding to selectins in leukocyte recruitment.","volume":"100","author":"McEver","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.300.3.729_bib42","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.102.16.1931","article-title":"P-selectin expression on platelets determines size and stability of platelet aggregates.","volume":"102","author":"Merten","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/jpet.300.3.729_bib43","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1073\/pnas.93.21.11877","article-title":"In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.","volume":"93","author":"Michelson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.300.3.729_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-0037-1615622","article-title":"P-selectin antagonism causes dose-dependent venous thrombosis inhibition.","volume":"85","author":"Myers","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib45","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1182\/blood.V89.2.541","article-title":"Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk.","volume":"89","author":"Napoleone","year":"1997","journal-title":"Blood"},{"key":"10.1124\/jpet.300.3.729_bib46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/359848a0","article-title":"Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selection on adherent platelets.","volume":"359","author":"Palabrica","year":"1992","journal-title":"Nature (Lond)"},{"key":"10.1124\/jpet.300.3.729_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1358863X9700200301","article-title":"Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention.","volume":"2","author":"Sakurai","year":"1997","journal-title":"Vasc Med"},{"key":"10.1124\/jpet.300.3.729_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00024382-199610000-00001","article-title":"Hemostatic parameters in sepsis patients treated with anti-TNF alpha-monoclonal antibodies.","volume":"6","author":"Salat","year":"1996","journal-title":"Shock"},{"key":"10.1124\/jpet.300.3.729_bib49","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0002-8703(98)70212-1","article-title":"Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction.","volume":"136","author":"Serebruany","year":"1998","journal-title":"Am Heart J"},{"key":"10.1124\/jpet.300.3.729_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1011280801335","article-title":"Usefulness of combining necrosis and platelet markers in triaging patients presenting with chest pain to the emergency department.","volume":"11","author":"Serebruany","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/jpet.300.3.729_bib51","first-page":"55","article-title":"Efficacy of CY1748, a monoclonal antibody directed against P-selectin, on deep vein thrombosis in cynomolgus monkeys.","volume":"18","author":"Shebuski","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.300.3.729_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9149(97)00945-4","article-title":"Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction.","volume":"81","author":"Shimomura","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.300.3.729_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/hh1301.092508","article-title":"Role for tissue factor pathway in murine models of vascular remodeling.","volume":"89","author":"Singh","year":"2001","journal-title":"Circ Res"},{"key":"10.1124\/jpet.300.3.729_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1124\/jpet.300.3.729_bib55","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1055\/s-0038-1650653","article-title":"Interleukin-6 stimulates coagulation, not fibrinolysis, in humans.","volume":"76","author":"Stouthard","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib56","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1091\/mbc.4.8.791","article-title":"Divergent fates of P- and E-selectins after their expression on the plasma membrane.","volume":"4","author":"Subramaniam","year":"1993","journal-title":"Mol Biol Cell"},{"key":"10.1124\/jpet.300.3.729_bib57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1657526","article-title":"Tissue factor in the pathogenesis of atherosclerosis.","volume":"78","author":"Taubman","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib58","first-page":"127","article-title":"Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.","volume":"33","author":"Taylor","year":"1991","journal-title":"Circ Shock"},{"key":"10.1124\/jpet.300.3.729_bib59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1657562","article-title":"Cytokines: triggers of clinical thrombotic disease.","volume":"78","author":"ten Cate","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3565(24)29425-8","article-title":"P-selectin antagonism with recombinant P-selectin glycoprotein ligand-1 (rPSGL-1) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces.","volume":"298","author":"Theoret","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.3.729_bib61","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-3565(25)12148-4","article-title":"Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis.","volume":"275","author":"Toombs","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.3.729_bib62","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1055\/s-0038-1657716","article-title":"Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.","volume":"78","author":"Uchiba","year":"1997","journal-title":"Thromb Haemost"},{"issue":"Suppl","key":"10.1124\/jpet.300.3.729_bib63","first-page":"688","article-title":"Mechanistic and pharmacological evaluation of NAPc2, a novel small protein inhibitor of the factor VIIa\/tissue factor complex.","volume":"77","author":"Vlasuk","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.300.3.729_bib65","first-page":"1","article-title":"The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interactions.","volume":"81","author":"Yang","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.300.3.729_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00365519909168321","article-title":"Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.","volume":"230","author":"Zhou","year":"1999","journal-title":"Scand J Clin Lab Invest Suppl"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524355144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524355144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.300.3.729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:14:51Z","timestamp":1740006891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524355144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0022356524355144"],"URL":"https:\/\/doi.org\/10.1124\/jpet.300.3.729","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Inflammatory Mediators in Thrombogenesis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.300.3.729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}